Related Experiment Video

Updated: Jun 3, 2026

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis
07:48

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis

Published on: January 7, 2019

The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins

Emma Salomonsson1, Victor L Thijssen, Arjan W Griffioen

  • 1Section Microbiology, Immunology, Glycobiology, Institute of Laboratory Medicine, Lund University, Sölvegatan 23, SE-223 62 Lund, Sweden.

The Journal of Biological Chemistry
|March 5, 2011
PubMed

Insights

The anti-cancer peptide anginex significantly enhances galectin-1 binding to glycoproteins. This interaction offers a promising new avenue for anti-angiogenesis cancer therapies targeting tumor vasculature.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Angiogenesis is crucial for cancer growth and metastasis.
  • Galectin-1 is upregulated in tumor endothelium and is a target for anti-angiogenic therapies.
  • Anginex is a peptide with demonstrated anti-angiogenic and anti-tumor properties.

Purpose of the Study:

  • To investigate the interaction between anginex and galectin-1.
  • To determine how anginex binding affects galectin-1's affinity for glycoproteins.
  • To explore anginex's interaction profile with other galectin family members.

Main Methods:

  • Biochemical assays to measure binding affinities.
  • Analysis of interactions between anginex, galectin-1, and various glycoproteins.
  • Testing anginex's interaction with a panel of galectins.

Main Results:

  • Anginex binding increases galectin-1's affinity for glycoproteins by 100- to 1000-fold.
  • Anginex interacts with galectin-2, -7, -8N, and -9N.
  • Anginex does not interact with galectin-3, -4, or -9C.

Conclusions:

  • Anginex binding modulates galectin-1's lectin activity, enhancing its interaction with target glycoproteins.
  • The specific interactions of anginex with certain galectins suggest targeted therapeutic potential.
  • These findings provide a molecular basis for anginex's anti-angiogenic activity and potential in cancer treatment.

More Related Videos

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Matrix Proteoglycans and Glycoproteins01:21

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...